Company Filing History:
Years Active: 2004-2014
Title: Innovations by Andreas Lubbertus Aloysius Johannes Dekker
Introduction
Andreas Lubbertus Aloysius Johannes Dekker is a notable inventor based in Maastricht, Netherlands. He holds a total of seven patents, showcasing his contributions to the field of medical technology and predictive modeling. His work focuses on improving treatment planning and patient outcomes through innovative approaches.
Latest Patents
One of Dekker's latest patents is titled "Dose distribution modeling by region from functional imaging." This invention utilizes functional imaging information to determine the probability of residual disease following treatment. By analyzing different characteristic levels across various regions of a tumor, the patent allows for a more tailored dose distribution. This method ensures that certain regions receive a higher dose while others receive a lesser dose, optimizing treatment efficacy and minimizing risks to normal tissue. Another significant patent is the "Knowledge-based interpretable predictive model for survival analysis." This model incorporates expert knowledge to train a predictive model that can output survival probabilities for patients, even when some data is missing. The graphical representation of this model aids physicians in understanding the relationships between predictive variables.
Career Highlights
Throughout his career, Dekker has worked with prominent companies such as Datex-Ohmeda, Inc. and Siemens Medical Solutions USA, Inc. His experience in these organizations has contributed to his expertise in medical technology and innovation.
Collaborations
Dekker has collaborated with notable professionals in his field, including Glenn Fung and Philippe Lambin. These partnerships have likely enhanced his research and development efforts.
Conclusion
Andreas Lubbertus Aloysius Johannes Dekker is a distinguished inventor whose work in medical technology and predictive modeling has the potential to significantly impact patient care. His innovative patents reflect a commitment to advancing treatment methodologies and improving survival outcomes for patients.